Product Information
KETOCONAZOLE 2% FOAM is a generic product labeled by Xiromed LLC, priced at $5.5972 per GM under NDC 70700016019. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on May 21, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/g
Manufacturer
Xiromed LLCNDC
70700016019
Classification
Generic
Dosage Form
AEROSOL, FOAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
KETOCONAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA213601FDA Approved
5/21/2021
TE Code
AB
On Market Since
5/21/2021
Pharmacological Classes
Price Statistics
The NADAC for KETOCONAZOLE 2% FOAM has been published 129 times since Apr 17, 2024, and over the history we have for it it has declined 16.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.5972 per GM |
|---|---|
| All-time high | $8.0876 (Dec 11, 2024) |
| All-time low | $5.2798 (Dec 17, 2025) |
| 52-week high | $6.3867 |
| 52-week low | $5.2798 |
| Median price | $6.3786 |
| Average price | $6.4014 |
| Largest weekly change | +9.2% (Nov 20, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 39% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Xiromed LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ketoconazole Foam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Azole Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of KETOCONAZOLE 2% FOAM?
The current National Average Drug Acquisition Cost (NADAC) for KETOCONAZOLE 2% FOAM, manufactured by Xiromed LLC, is $5.5972 per GM (NDC 70700016019), effective Sep 30, 2026.
How has the price of KETOCONAZOLE 2% FOAM changed over time?
Over the history we have for it, the NADAC for KETOCONAZOLE 2% FOAM has declined 16.1%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for KETOCONAZOLE 2% FOAM?
Since Apr 17, 2024, the NADAC for KETOCONAZOLE 2% FOAM has ranged from a low of $5.2798 (Dec 17, 2025) to a high of $8.0876 (Dec 11, 2024), with a median of $6.3786 per GM.
Are there cheaper alternatives to KETOCONAZOLE 2% FOAM?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, KETOCONAZOLE 2% FOAM, is $3.4406 per GM — about 39% below KETOCONAZOLE 2% FOAM.
Who manufactures KETOCONAZOLE 2% FOAM?
KETOCONAZOLE 2% FOAM (NDC 70700016019) is labeled by Xiromed LLC, and CMS classifies it as a generic product.